By ALM Staff | November 18, 2021
This suit was surfaced by Law.com Radar. Read the complaint here.
By ALM Staff | October 29, 2021
This suit was surfaced by Law.com Radar. Read the complaint here.
By ALM Staff | October 27, 2021
This suit was surfaced by Law.com Radar. Read the complaint here.
The Legal Intelligencer | Commentary
By Stephen J. Finley Jr. and Jonathan T. Woy | May 27, 2021
Comment k to Section 402A of the Restatement (Second) of Torts precludes all strict liability claims arising from injuries caused by certain categories of products, including prescription pharmaceuticals and medical devices.
The Legal Intelligencer | Commentary
By Chantal B. Norman and Justin M. Schiff | April 8, 2021
With a lack of federal guidance on this issue, states were left to fend for themselves and create their own guidelines as to how manufacturers of PPE would be protected from end users alleging they became infected with COVID-19 after utilizing their protective equipment.
By Michael A. Mora | March 18, 2021
Greenberg Traurig partner, Joshua R. Brown, said in certain instances some copying is unintentional and can be resolved without litigation, while in other situations there is willful intent that will require a resolution in the courts, such as in this lawsuit.
The Legal Intelligencer | News
By Max Mitchell | February 18, 2021
Defendants argued that the case had no connection to Philadelphia, and also raised the contention that numerous witnesses were afraid to travel to a more densely populated locale, where case counts of the COVID-19 virus have only recently begun to decline from record peaks.
The Legal Intelligencer | Analysis
By Robert Storace | October 14, 2020
A federal lawsuit was filed this week against Connecticut and Pennsylvania companies for allegedly using rawhide in their "No-Hide" dog chew products.
The Legal Intelligencer | News
By Erica Silverman | September 9, 2020
Litigator Karl Riley previously practiced at Snell & Wilmer, and more recently clerked for Ninth Circuit Judge Johnnie Rawlinson.
The Legal Intelligencer | Commentary
By Paola Pearson | August 17, 2020
While public health agencies like the U.S. Food and Drug Administration (FDA) and state health departments are focused on managing the COVID-19 pandemic, companies are quietly capitalizing on the surge in demand for products to keep us safe from the virus.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
The premier educational and networking event for employee benefits brokers and agents.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS